Clinical Trial Update: Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluates hysteroscopic repeat curettage as the first-line treatment for low-risk postmolar gestational trophoblastic neoplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Neoplasia

Snippet

Sponsor: Women's Hospital School Of Medicine Zhejiang University | Conditions: Gestational Trophoblastic Neoplasia | Phase 3 | Status: UNKNOWN